Increasing Walking and Bright Light Exposure to Improve Sleep in Community-Dwelling Persons with Alzheimer's Disease: Results of a Randomized, Controlled Trial

被引:155
|
作者
McCurry, Susan M. [1 ]
Pike, Kenneth C. [1 ]
Vitiello, Michael V. [2 ]
Logsdon, Rebecca G. [1 ]
Larson, Eric B. [3 ]
Teri, Linda [1 ]
机构
[1] Univ Washington, Dept Psychosocial & Community Hlth, Seattle, WA 98115 USA
[2] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98115 USA
[3] Grp Hlth Res Inst, Seattle, WA USA
关键词
sleep; Alzheimer's disease; walking; light; adherence; NURSING-HOME RESIDENTS; PLACEBO-CONTROLLED TRIAL; INSTITUTIONALIZED PATIENTS; PHYSICAL-ACTIVITY; DEMENTIA; DISTURBANCES; PREDICTORS; MELATONIN; INSOMNIA; CAREGIVERS;
D O I
10.1111/j.1532-5415.2011.03519.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
OBJECTIVES: To test the effects of walking, light exposure, and a combination intervention (walking, light, and sleep education) on the sleep of persons with Alzheimer's disease (AD). DESIGN: Randomized, controlled trial with blinded assessors. SETTING: Independent community living. PARTICIPANTS: One hundred thirty-two people with AD and their in-home caregivers. INTERVENTIONS: Participants were randomly assigned to one of three active treatments (walking, light, combination treatment) or contact control and received three or six in-home visits. MEASUREMENTS: Primary outcomes were participant total wake time based on wrist actigraphy and caregiver ratings of participant sleep quality on the Sleep Disorders Inventory (SDI). Secondary sleep outcomes included additional actigraphic measurements of sleep percentage, number of awakenings, and total sleep time. RESULTS: Participants in walking (P = .05), light (P = .04), and combination treatment (P = .01) had significantly greater improvements in total wake time at posttest (effect size 0.51-0.63) than controls but no significant improvement on the SDI. Moderate effect size improvements in actigraphic sleep percentage were also observed in active treatment participants. There were no significant differences between the active treatment groups and no group differences for any sleep outcomes at 6 months. Participants with better adherence (4 d/wk) to walking and light exposure recommendations had significantly less total wake time (P = .006) and better sleep efficiency (P = .005) at posttest than those with poorer adherence. CONCLUSION: Walking, light exposure, and their combination are potentially effective treatments for improving sleep in community-dwelling persons with AD, but consistent adherence to treatment recommendations is required. J Am Geriatr Soc 59: 1393-1402, 2011.
引用
收藏
页码:1393 / 1402
页数:10
相关论文
共 50 条
  • [31] Effect of Exercise and Cognitive Activity on Self-Reported Sleep Quality in Community-Dwelling Older Adults with Cognitive Complaints: A Randomized Controlled Trial
    Pa, Judy
    Goodson, William
    Bloch, Andrew
    King, Abby C.
    Yaffe, Kristine
    Barnes, Deborah E.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2014, 62 (12) : 2319 - 2326
  • [32] Combination Treatment in Alzheimer's Disease: Results of a Randomized, Controlled Trial with Cerebrolysin and Donepezil
    Alvarez, X. A.
    Cacabelos, R.
    Sampedro, C.
    Couceiro, V.
    Aleixandre, M.
    Vargas, M.
    Linares, C.
    Granizo, E.
    Garcia-Fantini, M.
    Baurecht, W.
    Doppler, E.
    Moessler, H.
    CURRENT ALZHEIMER RESEARCH, 2011, 8 (05) : 583 - 591
  • [33] Incidence of prescription vitamin B12 use in relation to diagnosis of Alzheimer's disease among community-dwelling persons
    Polonen, Satu
    Tiihonen, Miia
    Nykanen, Irma
    Taipale, Heidi
    Tolppanen, Anna-Maija
    Hartikainen, Sirpa
    JOURNAL OF PUBLIC HEALTH-HEIDELBERG, 2019, 27 (06): : 775 - 779
  • [34] Incidence of antidepressant use in community-dwelling persons with and without Alzheimer's disease: 13-year follow-up
    Puranen, Arto
    Taipale, Heidi
    Koponen, Marjaana
    Tanskanen, Antti
    Tolppanen, Anna-Maija
    Tiihonen, Jari
    Hartikainen, Sirpa
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 32 (01) : 94 - 101
  • [35] A randomized controlled Alzheimer’s disease prevention trial’s evolution into an exposure trial: The preadvise trial
    R. J. Kryscio
    E. L. Abner
    F. A. Schmitt
    P. J. Goodman
    M. Mendiondo
    A. Caban-Holt
    B. C. Dennis
    M. Mathews
    E. A. Klein
    J. J. Crowley
    The journal of nutrition, health & aging, 2013, 17 : 72 - 75
  • [36] Use of antidepressants among community-dwelling persons with Alzheimer's disease: a nationwide register-based study
    Laitinen, Marja-Liisa
    Lonnroos, Eija
    Bell, J. Simon
    Lavikainen, Piia
    Sulkava, Raimo
    Hartikainen, Sirpa
    INTERNATIONAL PSYCHOGERIATRICS, 2015, 27 (04) : 669 - 672
  • [37] Melatonin Fails to Improve Sleep or Agitation in Double-Blind Randomized Placebo-Controlled Trial of Institutionalized Patients With Alzheimer Disease
    Gehrman, Philip R.
    Connor, Donald J.
    Martin, Jennifer L.
    Shochat, Tamar
    Corey-Bloom, Jody
    Ancoli-Israel, Sonia
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (02) : 166 - 169
  • [38] Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: results from the GERAS II observational study
    Olazaran, Javier
    Aguera-Ortiz, Luis
    Maria Argimon, Josep
    Reed, Catherine
    Ciudad, Antonio
    Andrade, Paula
    Dilla, Tatiana
    INTERNATIONAL PSYCHOGERIATRICS, 2017, 29 (12) : 2081 - 2093
  • [39] Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer’s disease
    Heidi Juntunen
    Heidi Taipale
    Antti Tanskanen
    Anna-Maija Tolppanen
    Jari Tiihonen
    Sirpa Hartikainen
    Miia Tiihonen
    European Journal of Clinical Pharmacology, 2017, 73 : 1149 - 1158
  • [40] Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study
    Taipale, Heidi
    Lampela, Pasi
    Koponen, Marjaana
    Tanskanen, Antti
    Tiihonen, Jari
    Hartikainen, Sirpa
    Tolppanen, Anna-Maija
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (01) : 127 - 136